An injectable hyaluronic acid-tyramine hydrogel system for protein delivery.

Previously, we reported the independent tuning of mechanical strength (crosslinking density) and gelation rate of an injectable hydrogel system composed of hyaluronic acid-tyramine (HA-Tyr) conjugates. The hydrogels were formed through the oxidative coupling of tyramines which was catalyzed by hydrogen peroxide (H(2)O(2)) and horseradish peroxidase (HRP). Herein, we studied the encapsulation and release of model proteins using the HA-Tyr hydrogel. It was shown that the rapid gelation achieved by an optimal concentration of HRP could effectively encapsulate the proteins within the hydrogel network and thus prevented the undesired leakage of proteins into the surrounding tissues after injection. Hydrogels with different mechanical strengths were formed by changing the concentration of H(2)O(2) while maintaining the rapid gelation rate. The mechanical strength of the hydrogel controlled the release rate of proteins: stiff hydrogels released proteins slower compared to weak hydrogels. In phosphate buffer saline, alpha-amylase (negatively charged) was released sustainably from the hydrogel. Conversely, the release of lysozyme (positively charged) discontinued after the fourth hour due to electrostatic interactions with HA. In the presence of hyaluronidase, lysozymes were released continuously and completely from the hydrogel due to degradation of the hydrogel network. The activities of the released proteins were mostly retained which suggested that the HA-Tyr hydrogel is a suitable injectable and biodegradable system for the delivery of therapeutic proteins.

[1]  Glenn D Prestwich,et al.  Disulfide cross-linked hyaluronan hydrogels. , 2002, Biomacromolecules.

[2]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[3]  A. Metters,et al.  Hydrogels in controlled release formulations: network design and mathematical modeling. , 2006, Advanced drug delivery reviews.

[4]  P. Watt,et al.  Screening for peptide drugs from the natural repertoire of biodiverse protein folds , 2006, Nature Biotechnology.

[5]  P. Borgia,et al.  alpha-amylase from five strains of Bacillus amyloliquefaciens: evidence for identical primary structures , 1978, Journal of bacteriology.

[6]  M. Ferrer,et al.  Structure and dynamics of lysozyme encapsulated in a silica sol-gel matrix. , 2007, The journal of physical chemistry. B.

[7]  J. Feijen,et al.  Release of model proteins and basic fibroblast growth factor from in situ forming degradable dextran hydrogels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[8]  L. Brown Commercial challenges of protein drug delivery , 2005, Expert opinion on drug delivery.

[9]  B. Lee,et al.  In-situ injectable physically and chemically gelling NIPAAm-based copolymer system for embolization. , 2006, Biomacromolecules.

[10]  Robert Langer,et al.  Advances in Biomaterials, Drug Delivery, and Bionanotechnology , 2003 .

[11]  Allan S Hoffman,et al.  Hydrogels for biomedical applications. , 2002, Advanced drug delivery reviews.

[12]  W. Hennink,et al.  Release of recombinant human interleukin-2 from dextran-based hydrogels. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Yi Yan Yang,et al.  Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine conjugates for drug delivery and tissue engineering. , 2005, Chemical communications.

[14]  Christine E Schmidt,et al.  Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. , 2003, Biotechnology and bioengineering.

[15]  T. Miyata,et al.  Synthesis and characterization of stimuli-sensitive hydrogels having a different length of ethylene glycol chains carrying phosphate groups: loading and release of lysozyme , 2004, Journal of biomaterials science. Polymer edition.

[16]  Antonios G Mikos,et al.  Injectable matrices and scaffolds for drug delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[17]  J. Feijen,et al.  In vitro and in vivo protein delivery from in situ forming poly(ethylene glycol)-poly(lactide) hydrogels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[18]  T. Park,et al.  A new preparation method for protein loaded poly(D, L-lactic-co-glycolic acid) microspheres and protein release mechanism study. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[19]  J. Hubbell,et al.  Protein delivery from materials formed by self-selective conjugate addition reactions. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Glenn D Prestwich,et al.  In situ crosslinkable hyaluronan hydrogels for tissue engineering. , 2004, Biomaterials.

[21]  A. Metters,et al.  Poly(ethylene glycol) hydrogels formed by conjugate addition with controllable swelling, degradation, and release of pharmaceutically active proteins. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Charles H Tator,et al.  Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. , 2006, Biomaterials.

[23]  S. A. Marshall,et al.  Rational design and engineering of therapeutic proteins. , 2003, Drug discovery today.

[24]  A. Metters,et al.  Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Wim E Hennink,et al.  Recombinant gelatin hydrogels for the sustained release of proteins. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Jae Sun Yoo,et al.  Novel injectable pH and temperature sensitive block copolymer hydrogel. , 2005, Biomacromolecules.

[27]  J. Fitter,et al.  Structural stability and unfolding properties of thermostable bacterial alpha-amylases: a comparative study of homologous enzymes. , 2004, Biochemistry.

[28]  A Hatefi,et al.  Biodegradable injectable in situ forming drug delivery systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Glenn D Prestwich,et al.  Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. , 2005, Biomaterials.

[30]  M. Kurisawa,et al.  An injectable enzymatically crosslinked hyaluronic acid- hydrogel system with independent tuning of mechanical strength and gelation rate. , 2008, Soft matter.

[31]  N. Peppas,et al.  Oral delivery of insulin using pH-responsive complexation gels. , 1999, Journal of pharmaceutical sciences.

[32]  Y. Bae,et al.  Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[33]  R. Canfield THE AMINO ACID SEQUENCE OF EGG WHITE LYSOZYME. , 1963, The Journal of biological chemistry.

[34]  M. Gibaldi,et al.  Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs , 2003 .

[35]  Anna Gutowska,et al.  Thermogelling biodegradable copolymer aqueous solutions for injectable protein delivery and tissue engineering. , 2002, Biomacromolecules.

[36]  Wim E. Hennink,et al.  Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles , 2000, Pharmaceutical Research.

[37]  Richard W. Baker,et al.  Controlled Release of Biologically Active Agents , 1987 .